Novo Nordisk A/S ADR (NY: NVO )
141.10
-1.88
(-1.31%)
Streaming Delayed Price
Updated: 10:13 AM EDT, Jul 3, 2024
Add to My Watchlist
All News about Novo Nordisk A/S ADR![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]()
P/E Ratio Insights for Novo Nordisk
January 11, 2024
Via Benzinga
![]()
Looking At Novo Nordisk's Recent Unusual Options Activity
January 10, 2024
Via Benzinga
![]() ![]()
FDA Finds No Evidence Weight-Loss Drugs Cause Suicidal Thoughts
January 11, 2024
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]()
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
January 08, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|